Video Experimental Relacionado

Updated: Jan 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Diseño de Potentes Inhibidores de la Proteasa del VIH-1 Mediante Aprendizaje Automático y Enfoques QSAR

Saba Ali¹, Ismail Dwi Putra², Hathaichanok Chuntakaruk³

¹Center of Excellence in Computational Chemistry (CECC), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.

|January 1, 2026

Resumen

Los investigadores desarrollaron nuevos inhibidores de la proteasa del Virus de la Inmunodeficiencia Humana tipo 1 (VIH-1) utilizando modelos de aprendizaje automático y QSAR. Estos compuestos novedosos muestran potencial para superar la resistencia a los medicamentos, superando a los tratamientos existentes contra las variantes del VIH-1.

Sus antecedentes:

El Síndrome de Inmunodeficiencia Adquirida (SIDA), causado por el Virus de la Inmunodeficiencia Humana tipo 1 (VIH-1), presenta un desafío persistente para la salud mundial.
La resistencia a los medicamentos, especialmente a los inhibidores de la proteasa como el Darunavir, limita la efectividad de las terapias antirretrovirales actuales contra las variantes del VIH-1.

Conclusiones:

El enfoque integrado QSAR-ML y basado en la estructura identificó con éxito candidatos prometedores a nuevos inhibidores de la proteasa del VIH-1.
Los compuestos diseñados demuestran potencial para superar los mecanismos de resistencia a los medicamentos existentes en el tratamiento del VIH-1.
Este estudio proporciona una base para el desarrollo de terapias antirretrovirales de próxima generación contra cepas de VIH-1 resistentes.

Palabras clave:

inhibidores de la proteasa del VIH-1 aprendizaje automático QSAR resistencia a los medicamentos descubrimiento de fármacos

Más Videos Relacionados

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Videos de Conceptos Relacionados

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...